• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Patient, Physician use of Telemedicine According to Dr. Peter Alperin of Doximity and the 2020 State of Telemedicine Report

Podcast

In this week's episode of Tuning Into The C-Suite, MHE's Briana Contreras spoke with Dr. Peter Alperin, Vice President of Doximity and a physician in private practice in San Francisco. They discussed the recently released 2020 State of Telemedicine Report conducted by Doximity and how it reflects into the adoption of telemedicine among physicians and patients alike, how the report analyzed telemedicine’s usage since COVID-19 and its market potential beyond the pandemic.

To listen to more episodes featured on Tuning Into The C-Suite, visit us on Spotify, Apple Podcasts and iHeartRadio.

Dr. Peter Alperin


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.